Page 15 - Read Online

Shimizu et al. Hepatoma Res 2020;6:12 I http://dx.doi.org/10.20517/2394-5079.2019.48 Page 9 of 9

2018;69:182-236.
13. Marrero JA, Kulik LM, Sirlin CB, Zhu AX, Finn RS, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018
practice guidance by the American Association for the Study of Liver Diseases. Hepatology 2018;68:723-50.
14. Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant 2013;48:452-8.
15. Hwang J, Kim YK, Jeong WK, Choi D, Rhim H, et al. Nonhypervascular hypointense nodules at gadoxetic acid enhanced MR imaging in
chronic liver disease. Radiology 2015;276:137-46.
16. Kwon HJ, Byun JH, Kim JY, Hong GS, Won HJ, et al. Differentiation of small (≤ 2 cm) hepatocellular carcinomas from small benign
nodules in cirrhotic liver on gadoxetic acid-enhanced and diffusion-weighted magnetic resonance images. Abdom Imaging 2015;40:64-75.
17. Inoue T, Hyodo T, Murakami T, Takayama Y, Nishie A, et al. Hypovascular hepatic nodules showing hypointense on the hepatobiliary-
phase image of Gd-EOB-DTPA-enhanced MRI to develop a hypervascular hepatocellular carcinoma: A nationwide retrospective study on
their natural course and risk factors. Dig Dis 2013;31:472-9.
18. Chou CT, Chou JM, Chang TA, Huang SF, Chen CB, et al. Differentiation between dysplastic nodule and early-stage hepatocellular
carcinoma: the utility of conventional MR imaging. World J Gastroenterol 2013;19:7433-9.
19. Jiang T, Xu JH, Zou Y, Chen R, Peng LR, et al. Diffusion-weighted imaging (DWI) of hepatocellular carcinomas: a retrospective analysis
of the correlation between qualitative and quantitative DWI and tumor grade. Clin Radiol 2017;72:465-72.
20. Okamura S, Sumie S, Tonan T, Nakano M, Satani M, et al. Diffusion-weighted magnetic resonance imaging predicts malignant potential
in small hepatocellular carcinoma. Dig Liver Dis 2016;48:945-52.
21. Mariño Z, Darnell A, Lens S, Sapena V, Díaz A, et al. Time association between hepatitis C therapy and hepatocellular carcinoma
emergence in cirrhosis: Relevance of non-characterized nodules. J Hepatol 2019;70:874-84.
22. Yoshimasu Y, Furuichi Y, Kasai Y, Takeuchi H, Sugimoto K, et al. Predictive factors for hepatocellular carcinoma occurrence or
recurrence after direct-acting antiviral agents in patients with chronic hepatitis C. J Gastrointest Liver Dis 2019;28:63-71.
23. Villani R, Vendemiale G, Serviddio G. Molecular mechanisms involved in HCC recurrence after direct-acting antiviral therapy. Int J Mol
Sci 2018;20:49.
24. Debes JD, van Tilborg M, Groothuismink ZMA, Hansen BE, Schulze Zur Wiesch J, et al. Levels of cytokines in serum associate
with development of hepatocellular carcinoma in patients with HCV infection treated with direct-acting antivirals. Gastroenterology
2018;154:515-7.e3.
25. Nakanishi M, Chuma M, Hige S, Omatsu T, Yokoo H, et al. Relationship between diffusion-weighted magnetic resonance imaging and
histological tumor grading of hepatocellular carcinoma. Ann Surg Oncol 2012;19:1302-9.
26. Shankar S, Kalra N, Bhatia A, Srinivasan R, Singh P, et al. Role of diffusion weighted imaging (DWI) for hepatocellular carcinoma (HCC)
detection and its grading on 3T MRI: a prospective study. J Clin Exp Hepatol 2016;6:303-10.
27. Granata V, Fusco R, Filice S, Catalano O, Piccirillo M, et al. The current role and future prospectives of functional parameters by
diffusion weighted imaging in the assessment of histologic grade of HCC. Infect Agent Cancer 2018;13:23.